Imsidolimab significantly improves skin clearance in patients with generalized pustular psoriasis in two phase 3 trials.

The older I get, the more my skin seems to throw out the occasional curveball—mysterious lumps, bumps, pimples and marks, things that weren’t there yesterday suddenly catch my eye. Some I can brush ...

Localized pustular psoriasis is a term that refers to a limited area of small pus-filled blisters on your skin, typically on your hands or feet. It is distinct from generalized pustular psoriasis (GPP ...

“EFFISAYIL™ 2 is the first and largest multinational randomized clinical trial to evaluate a treatment for the prevention of GPP flares,” said Bruce Strober, MD, PhD, Clinical Professor, Dermatology, ...

Folliculitis is a common skin condition that occurs when hair follicles become inflamed due to infection, irritation, or blockage. The most frequent cause is a bacterial infection, though fungi and ...

Imsidolimab is an investigational humanized IgG4 antibody that inhibits the function of the interleukin-36 receptor. Findings from two phase 3 trials showed skin clearance was achieved and maintained ...

Vanda Pharmaceuticals and AnaptysBio have announced a global license agreement for the development and commercialization of imsidolimab, an IL-36R antagonist that has completed two successful Phase 3 ...

Tender, rupturing pustule on the chin A man complained of mild-to-moderate sensitivity in his lower incisor whenever he chewed for the past year. Four months ago, a painful tender swelling developed ...

(RTTNews) - Vanda Pharmaceuticals Inc. (VNDA) on Wednesday said the U.S. Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for imsidolimab for the treatment of ...

When my skin is angry and my perioral dermatitis is at its worst, I recommend Avène’s cicalfate+ restorative protective cream ...